financetom
Business
financetom
/
Business
/
Law firms Quinn Emanuel, Cohen Milstein get $102 mln from stock lending settlement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Law firms Quinn Emanuel, Cohen Milstein get $102 mln from stock lending settlement
Sep 12, 2024 12:00 PM

Sept 12 (Reuters) - A U.S. judge has awarded $102

million in legal fees to law firms Quinn Emanuel Urquhart &

Sullivan and Cohen Milstein Sellers & Toll for their work on a

$580 million settlement for investors who accused major banks of

conspiring to curb competition in the stock lending market.

In an order on Wednesday, U.S. District Judge Katherine Polk

Failla in New York called the legal fee amount "fair and

reasonable," amounting to 17.06% of the settlement funds so far

in the case.

The institutional investors that filed the lawsuit in 2017

claimed a group of big banks had conspired to prevent

modernization in the trillion-dollar market for stock lending,

boycotting startup firms.

The investors alleged they had been charged excessive fees

for such lending, which involves the temporary transfer of stock

between investors.

Goldman Sachs ( GS ), JPMorgan ( JPM ), Morgan Stanley ( MS ), UBS, and Credit

Suisse agreed collectively to pay $580 million to settle the

antitrust lawsuit. Bank of America ( BAC ) is the lone remaining

defendant.

Lawyers for the class plaintiffs declined to comment, and

the banks either had no immediate comment or did not immediately

respond to a request for one. The settling banks and Bank of

America ( BAC ) have denied any wrongdoing.

The co-lead attorneys told the judge in May that they had

spent more than 180,000 hours of attorney time over six years

without pay in the case.

The class lawyers said that the case involved 100

depositions and "more than half a billion pages of produced

documents."

The settlements with the banks required new antitrust

compliance measures and other reforms for defendant EquiLend,

which was a joint venture among the banks. The class attorneys

valued the industry reforms at $319 million, settlement papers

show.

Failla in her order said the $102 million was "appropriate

to the specific circumstances of this action, and consistent

with awards in similar cases."

The case is Iowa Public Employees' Retirement System et al v

Bank of America Corp ( BAC ) et al, U.S. District Court, Southern

District of New York, No. 17-cv-06221.

Read more:

Goldman, JPMorgan ( JPM ), Morgan Stanley ( MS ), UBS in $499 mln stock

lending settlement

Credit Suisse entities agree to settle lawsuit in U.S. for

$81 million - court filing

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Salesforce Checks Show Stable Demand, Foreign-Exchange Headwinds, Morgan Stanley Says
Salesforce Checks Show Stable Demand, Foreign-Exchange Headwinds, Morgan Stanley Says
Feb 24, 2025
03:17 PM EST, 02/24/2025 (MT Newswires) -- Salesforce's ( CRM ) fourth-quarter results are expected to reflect stable demand and artificial intelligence traction, but foreign currency fluctuations and a recent C-suite shuffle pose headwinds heading into fiscal 2026, Morgan Stanley said in a note. Channel checks indicate that demand was likely stable in the fourth quarter, while the customer relationship...
Clover Health Investments Set for 'Strong' 2025 Revenue Guidance, UBS Says
Clover Health Investments Set for 'Strong' 2025 Revenue Guidance, UBS Says
Feb 24, 2025
03:25 PM EST, 02/24/2025 (MT Newswires) -- Clover Health Investments ( CLOV ) is poised for strong 2025 revenue guidance with the outlook for the medical loss ratio less clear, UBS Securities said Monday in a report. In Q4 results set for Thursday, the focus will be on how the company's newfound growth will translate for MLR and adjusted earnings...
Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list
Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list
Feb 24, 2025
...
Market Chatter: Citigroup's Global Head of Real Estate, Gaming, Lodging Leaves
Market Chatter: Citigroup's Global Head of Real Estate, Gaming, Lodging Leaves
Feb 24, 2025
03:18 PM EST, 02/24/2025 (MT Newswires) -- Citigroup's ( C ) global head of real estate, gaming, and lodging, Matthew Greenberger, has left the firm, Bloomberg reported Monday, citing sources with knowledge of the matter. Paul Ingrassia will serve as the interim head, the media outlet reported. An email sent to Greenberger's work account bounced back, confirming his departure, Bloomberg...
Copyright 2023-2026 - www.financetom.com All Rights Reserved